🔎 Trials Near Me

Utama › Kanser Kolorektal › Oklahoma › Oklahoma City

Kajian klinikal Kanser Kolorektal di Oklahoma City, OK

22 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi dalam dan sekitar Oklahoma City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Vanguard Study: Testing a New Way to Screen for Cancer

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 45 hingga 75 · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06995898

Family Communications After Genetic Testing

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Mercy Hospital Oklahoma City, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07143487

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • University of Oklahoma, Oklahoma City
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Mercy Hospital Oklahoma City, Oklahoma City
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Mengambil pesertaFasa 1
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05803382

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

Mengambil pesertaFasa 1
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06102902

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Mengambil pesertaFasa 1/2
  • Stephenson Cancer Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Oklahoma, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Mengambil pesertaFasa 1
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06696768

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Mengambil pesertaFasa 3
  • Clinical Study Site, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07228832

A Study of DM002 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06751329

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Mengambil pesertaFasa 1/2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT05691491

Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

Mengambil peserta
  • TSET Health Promotion Research Center, Oklahoma City
Umur 45 hingga 75 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07254910

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Stephenson Cancer Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT04657068

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • SSM OKC Hightower Clinical, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT03526835

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Mengambil pesertaFasa 2
  • Hightower Clinical, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06937177

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Mengambil pesertaKajian pemerhatian
  • Mercy Hospital - OKC, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07327489

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • OU Stephenson Cancer Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT06026410

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Mengambil pesertaFasa 1
  • OU Health Stephenson Cancer Center, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT06720987

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • Mercy Hospital Oklahoma City, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Mac 2026 · NCT07018869

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Mercy Hospital Oklahoma City, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Mengambil pesertaKajian pemerhatian
  • Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2025 · NCT05234177

Kajian Kanser Kolorektal di bandar lain

Kajian lain di Oklahoma City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.